These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 108011)
41. Skin carcinogenesis tests in mice of derivatives of 7,12-dimethylbenz[a]anthracene substituted in the 'A' ring. Lijinsky W; Manning WB; Andrews AW Carcinogenesis; 1983 Oct; 4(10):1221-4. PubMed ID: 6413083 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethylbenz(a)anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene. Slaga TJ; Boutwell RK Cancer Res; 1977 Jan; 37(1):128-33. PubMed ID: 401469 [TBL] [Abstract][Full Text] [Related]
43. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[alpha]anthracene. Watabe T; Ishizuka T; Isobe M; Ozawa N Science; 1982 Jan; 215(4531):403-5. PubMed ID: 6800033 [TBL] [Abstract][Full Text] [Related]
44. Tumor-initiating activity, mutagenicity, and metabolism of methylated anthracenes. La Voie EJ; Coleman DT; Rice JE; Geddie NG; Hoffmann D Carcinogenesis; 1985 Oct; 6(10):1483-8. PubMed ID: 3899400 [TBL] [Abstract][Full Text] [Related]
45. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
46. Evidence that benzo(a)anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. Levin W; Thakker DR; Wood AW; Chang RL; Lehr RE; Jerina DM; Conney AH Cancer Res; 1978 Jun; 38(6):1705-10. PubMed ID: 647681 [No Abstract] [Full Text] [Related]
47. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480 [TBL] [Abstract][Full Text] [Related]
48. Separation of initiating and promoting effects of the skin carcinogen 7-bromomethylbenz(a)anthracene. Scribner NK; Scribner JD Carcinogenesis; 1980 Jan; 1(1):97-100. PubMed ID: 22282986 [TBL] [Abstract][Full Text] [Related]
49. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells. Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
51. Mutagenicity and cytotoxicity of benz[alpha]anthracene diol epoxides and tetrahydro-epoxides: exceptional activity of the bay region 1,2-epoxides. Wood AW; Chang RL; Levin W; Lehr RE; Schaefer-Ridder M; Karle JM; Jerina DM; Conney AH Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2746-50. PubMed ID: 331315 [TBL] [Abstract][Full Text] [Related]
52. The effects of benzoflavones on polycyclic hydrocarbon metabolism and skin tumor initiation. Slaga TJ; Thompson S; Berry DL; Digiovanni J; Juchau MR; Viaje A Chem Biol Interact; 1977 Jun; 17(3):297-312. PubMed ID: 407010 [TBL] [Abstract][Full Text] [Related]
53. Microsome-mediated mutagenicities of the dihydrodiols of 7,12-dimethylbenz[a]anthracene: high mutagenic activity of the 3,4-dihydrodiol. Malaveille C; Bartsch H; Tierney B; Grover PL; Sims P Biochem Biophys Res Commun; 1978 Aug; 83(4):1468-73. PubMed ID: 100114 [No Abstract] [Full Text] [Related]
54. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test. Coombs MM; Dixon C; Kissonerghis AM Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712 [TBL] [Abstract][Full Text] [Related]
55. Tumor-initiating activity of the dihydrodiols of 8-methylbenz[a]anthracene and 8-hydroxymethylbenz[a]anthracene. Wislocki PG; Fiorentini KM; Fu PP; Chou MW; Yang SK; Lu AY Carcinogenesis; 1981; 2(6):507-9. PubMed ID: 7273331 [TBL] [Abstract][Full Text] [Related]
56. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665 [TBL] [Abstract][Full Text] [Related]
57. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
58. Tumour initiation in mouse skin by 7,12-dimethylbenz[a]anthracene: irrelevance of systemic activation. Pyerin WG; Hecker E Cancer Lett; 1980 Feb; 8(4):317-21. PubMed ID: 6768444 [TBL] [Abstract][Full Text] [Related]
59. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. DiGiovanni J; Rymer J; Slaga TJ; Boutwell RK Carcinogenesis; 1982; 3(4):371-5. PubMed ID: 6284398 [TBL] [Abstract][Full Text] [Related]